Open Access Open Access  Restricted Access Subscription Access

A Review of Gentamicin Medicine

Muralinath E., Mr. Vonteru Munisekhar, Dr. P. Prabhavathi., K. Suparnalatha., M. Harshita., Dr. G. Rajeswari., Sravani Pragna. K., Guruprasad M.

Abstract


An aminoglycoside antibiotic called gentamicin is used to treat a variety of gram-negative infections. To improve the likelihood of a successful course of treatment for bacterial septicemia, meningitis, urinary tract infections, gastrointestinal tract infections, and soft tissue infections, it should be specified based on patient age, symptoms, signs at presentation, and local antimicrobial resistance patterns. As a pertinent medication for the treatment of nosocomial and community-acquired infections, this exercise teaches how to evaluate gentamicin's indications, action mechanism, and contraindications. The primary administration routes, adverse event profile, and other important elements (such as off-label usage, dosage, pharmacodynamics, pharmacokinetics, and monitoring) relevant to the healthcare team's use of gentamicin will also be highlighted in this activity.


Full Text:

PDF

References


Phillips, I., Eykyn, S., King, B. A., Jenkins, C., Warren, C. A., & Shannon, K. P. (1977). The in vitro antibacterial activity of nine aminoglycosides and spectinomycin on clinical isolates of common Gram-negative bacteria. Journal of Antimicrobial Chemotherapy, 3(5), 403–410.

Hathorn, E., Dhasmana, D., Duley, L., & Ross, J. D. (2014). The effectiveness of gentamicin in the treatment of Neisseria gonorrhoeae: A systematic review. Systematic Reviews, 3, Article 104.

Finland, M., Garner, C., Wilcox, C., & Sabath, L. D. (1976). Susceptibility of pneumococci and Haemophilus influenzae to antibacterial agents. Antimicrobial Agents and Chemotherapy, 9(2), 274–287.

Kadry, A. A., Fouda, S. I., Elkhizzi, N. A., & Shibl, A. M. (2003). Correlation between susceptibility and BRO type enzyme of Moraxella catarrhalis strains. International Journal of Antimicrobial Agents, 22(5), 532–536.

Beganovic, M., Luther, M. K., Rice, L. B., Arias, C. A., Rybak, M. J., & LaPlante, K. L. (2018). A review of combination antimicrobial therapy for Enterococcus faecalis bloodstream infections and infective endocarditis. Clinical Infectious Diseases, 67(2), 303–309.

Kohanski, M. A., Dwyer, D. J., Hayete, B., Lawrence, C. A., & Collins, J. J. (2007). A common mechanism of cellular death induced by bactericidal antibiotics. Cell, 130(5), 797–810.

Wood, M. J., & Farrell, W. (1976). Comparison of urinary excretion of tobramycin and gentamicin in adults. The Journal of Infectious Diseases, 134(Suppl.), S133–S136.

Records, R. E. (1976). Gentamicin in ophthalmology. Survey of Ophthalmology, 21(1), 49–58.

Bratzler, D. W., Dellinger, E. P., Olsen, K. M., Perl, T. M., Auwaerter, P. G., Bolon, M. K., Fish, D. N., Napolitano, L. M., Sawyer, R. G., Slain, D., Steinberg, J. P., & Weinstein, R. A. (2013). Clinical practice guidelines for antimicrobial prophylaxis in surgery. American Journal of Health-System Pharmacy, 70(3), 195–283.

Vogelman, B., & Craig, W. A. (1986). Kinetics of antimicrobial activity. The Journal of Pediatrics, 108(5 Pt. 2), 835–840.

National Institute of Child Health and Human Development. (2024, June 15). Gentamicin. In Drugs and Lactation Database (LactMed®). National Library of Medicine. [Verify the specific entry URL before submission.]

Fausti, S. A., Henry, J. A., Schaffer, H. I., Olson, D. J., Frey, R. H., & McDonald, W. J. (1992). High-frequency audiometric monitoring for early detection of aminoglycoside ototoxicity. The Journal of Infectious Diseases, 165(6), 1026–1032.

Kahlmeter, G., & Dahlager, J. I. (1984). Aminoglycoside toxicity: A review of clinical studies published between 1975 and 1982. Journal of Antimicrobial Chemotherapy, 13(Suppl. A), 9–22.

Barrons, R. W. (1997). Drug-induced neuromuscular blockade and myasthenia gravis. Pharmacotherapy, 17(6), 1220–1232.

Lawson, D. H., Tilstone, W. J., Gray, J. M., & Srivastava, P. K. (1982). Effect of furosemide on the pharmacokinetics of gentamicin in patients. The Journal of Clinical Pharmacology, 22(5–6), 254–258.

Nicolau, D. P., Freeman, C. D., Belliveau, P. P., Nightingale, C. H., Ross, J. W., & Quintiliani, R. (1995). Experience with a once-daily aminoglycoside program administered to 2,184 adult patients. Antimicrobial Agents and Chemotherapy, 39(3), 650–655.

Connolly, M., McAdoo, J., & Bourke, J. F. (2007). Gentamicin-induced anaphylaxis. Irish Journal of Medical Science, 176(4), 317–318.


Refbacks

  • There are currently no refbacks.